METHODIST HOSPITAL
1. Target Overview & Investment Thesis
METHODIST HOSPITAL is a 1729-bed large academic medical center in BEXAR, TX with $2.42B in net patient revenue and a 22.9% operating margin. The hospital serves a payer mix of 18.9% Medicare, 2.4% Medicaid, and 78.8% commercial.
Thesis: Platform Growth. Our ML models identify $177.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 22.9% to 30.3% (+736bps).
| Net Revenue HCRIS | $2.42B |
| Current EBITDA COMPUTED | $553.5M |
| Operating Margin COMPUTED | 22.9% |
| Occupancy HCRIS | 81.9% |
| Revenue / Bed COMPUTED | $1.4M |
| Net-to-Gross HCRIS | 13.3% |
| Distress Probability ML | 43.3% |
2. Market Context & Competitive Position
TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of 22.9% places it above the state median. Among 53 size-comparable peers (864-3458 beds), the median margin is -7.5%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (864-3458), prioritizing same-state peers. 53 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| METHODIST HOSPITAL (Target) | TX | 1729 | $2.42B | 22.9% |
| NEW YORK PRESBYTERIAN HOSPITAL | NY | 2850 | $7.69B | -1.4% |
| NYU LANGONE HOSPITALS | NY | 1618 | $7.24B | -7.8% |
| CLEVELAND CLINIC HOSPITAL | OH | 1326 | $6.38B | -17.7% |
| VANDERBILT UNIVERSITY MEDICAL | TN | 1084 | $5.44B | -15.9% |
| ADVENTHEALTH ORLANDO | FL | 2738 | $5.40B | 2.5% |
| UNIV OF MI HOSPITALS & HLTH CT | MI | 951 | $4.62B | -1.4% |
| CEDARS-SINAI MEDICAL CENTER | CA | 908 | $3.92B | -5.5% |
| INDIANA UNIVERSITY HEALTH | IN | 1269 | $3.58B | -38.4% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $177.9M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $50.8M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $48.3M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $47.9M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $29.4M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $1.5M | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $553.5M |
| + RCM Uplift | +$177.9M |
| Pro Forma EBITDA | $731.5M |
| Current Margin | 22.9% |
| Pro Forma Margin | 30.3% |
| WC Released (1x) | $92.7M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $851.6M | $5.43B | 6.38x | 44.9% |
| Base (11x exit) | 10.0x | 11.0x | $851.6M | $6.25B | 7.34x | 49.0% |
| Bull Case | 9.0x | 11.0x | $766.4M | $7.11B | 9.28x | 56.1% |
| Bull (12x exit) | 9.0x | 12.0x | $766.4M | $7.99B | 10.42x | 59.8% |
| Bear Case | 11.0x | 10.0x | $936.7M | $4.26B | 4.55x | 35.4% |
| Bear (11x exit) | 11.0x | 11.0x | $936.7M | $5.00B | 5.33x | 39.8% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 53 hospitals with 864-3458 beds
- Same-state prioritization (n=5)
- Comp margins: P25=-17.9% / P50=-7.5% / P75=0.4%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.